SPOTLIGHT -
A New Combination Therapy Regimen Shows Promising Results For Prostate Cancer
TALAPRO-2 demonstrated that using talazoparib in combination with enzalutamide may reduce the risk of disease progression or death by 37%.
Read More
Thomas K. Varghese Jr. MD, MS, MBA, FACS, Named President-Elect of Society of University Surgeons
Varghese, known for his innovative research in perioperative care and mentorship to physician-scientists, will become SUS President in February 2024.
Three Talented Researchers Recognized as Endowed Chairs
Huntsman Cancer Institute at the University of Utah congratulates three of their newest endowed chairs.
Moderate Exercise Helps Patients With CRC Live Longer By Reducing Inflammation and Improving Gut Bacteria, Including in Patients Who Are Obese
Regular physical activity can extend the lives of patients with colorectal cancer, according to a study looking at the impact of exercise on the gut microbiome of cancer patients.
Tusamitamab Ravtansine Plus Pembrolizumab With or Without Chemo Elicits Responses in CEACAM5+ NSCLC
Cemiplimab Monotherapy Induces Durable OS, PFS Benefits in PD-L1+ NSCLC With Brain Metastases
Four Cycles of Chemotherapy Plus Tremelimumab and Durvalumab Demonstrate Optimized Outcomes in Metastatic NSCLC
Taletrectinib Elicits Durable Responses in TKI-Naïve and Crizotinib-Pretreated ROS1+ NSCLC
